Literature DB >> 14573737

Clinical practice. Gout.

Robert A Terkeltaub1.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 14573737     DOI： 10.1056/NEJMcp030733

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  120 in total

1.  [Allopurinol-induced hypersensitivity syndrome resulting in death].

Authors:  Sören Laurisch; Maren Jaedtke; Reyhan Demir; Sajoscha A Sorrentino; Jan T Kielstein; Hans-Oliver Rennekampff; Peter M Vogt; Gerd P Meyer; Martin Fuchs; Gunnar Klein; Hartmut Drexler; Bernhard Schieffer; L Christian Napp
Journal:  Med Klin (Munich)       Date:  2010-04

2.  The pharmacokinetics of oxypurinol in people with gout.

Authors:  Sophie L Stocker; Andrew J McLachlan; Radojka M Savic; Carl M Kirkpatrick; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Br J Clin Pharmacol       Date:  2012-09       Impact factor: 4.335

3.  Rasburicase treatment in severe tophaceous gout: a novel therapeutic option.

Authors:  J D Moolenburgh; M K Reinders; T L Th A Jansen
Journal:  Clin Rheumatol       Date:  2005-10-25       Impact factor: 2.980

4.  Fatal allopurinol hypersensitivity syndrome after treatment of asymptomatic hyperuricaemia.

Authors:  Alfonso Gutiérrez-Macías; Eva Lizarralde-Palacios; Pedro Martínez-Odriozola; Felipe Miguel-De la Villa
Journal:  BMJ       Date:  2005-09-17

5.  Successful treatment of chronic tophaceous gout with infliximab (Remicade).

Authors:  Christoph Fiehn; Martin Zeier
Journal:  Rheumatol Int       Date:  2005-06-03       Impact factor: 2.631

6.  HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.

Authors:  Shuen-Iu Hung; Wen-Hung Chung; Lieh-Bang Liou; Chen-Chung Chu; Marie Lin; Hsien-Ping Huang; Yen-Ling Lin; Joung-Liang Lan; Li-Cheng Yang; Hong-Shang Hong; Ming-Jing Chen; Ping-Chin Lai; Mai-Szu Wu; Chia-Yu Chu; Kuo-Hsien Wang; Chien-Hsiun Chen; Cathy S J Fann; Jer-Yuarn Wu; Yuan-Tsong Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-02       Impact factor: 11.205

7.  [Hyperuricemia and gout: diagnosis and therapy].

Authors:  A K Tausche; S Unger; K Richter; C Wunderlich; J Grässler; B Roch; H E Schröder
Journal:  Internist (Berl)       Date:  2006-05       Impact factor: 0.743

Review 8.  Treatment Options for Gout.

Authors:  Bettina Engel; Johannes Just; Markus Bleckwenn; Klaus Weckbecker
Journal:  Dtsch Arztebl Int       Date:  2017-03-31       Impact factor: 5.594

9.  Plasma urate and Parkinson's disease in the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Honglei Chen; Thomas H Mosley; Alvaro Alonso; Xuemei Huang
Journal:  Am J Epidemiol       Date:  2009-03-18       Impact factor: 4.897

Review 10.  Quality of life and quality of care for patients with gout.

Authors:  Jasvinder A Singh
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.